Baxter International | BAX - Trade Debtors


Baxter International reported $1.7B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
AngioDynamics USD 44.43M 1.79M Sep/2025
Artivion USD 103.68M 6.31M Dec/2025
AtriCure USD 71.31M 4.66M Mar/2026
Avanos Medical USD 103M 800K Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Fresenius EUR 3.78B 299M Dec/2025
Globus Medical USD 735.44M 8.23M Mar/2026
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
ICU Medical USD 180.52M 11.03M Dec/2025
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Laboratory Of America USD 2.45B 189.8M Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Quest Diagnostics USD 1.59B 179M Mar/2026
Smith & Nephew USD 1.48B 85M Dec/2025
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
Terumo JPY 217.57B 2.28B Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026